Step 1 topics → Biochemistry → Glycogen Metabolism

Glycogen Metabolism

Glycogen metabolism is one of the highest-yield biochemistry topics on USMLE Step 1, and it gets tested from multiple angles simultaneously: enzyme mechanisms, hormonal regulation, and clinical disease phenotypes. The core concept is that glycogen is a glucose storage polymer built and broken down by distinct enzyme sets, with liver glycogen serving blood glucose homeostasis and muscle glycogen serving local energy needs only. The exam loves to exploit the fact that these two depots behave differently — especially the muscle's lack of glucose-6-phosphatase, which is a favorite trap.

Step 1 tests this topic through direct recall (which enzyme makes alpha-1,6 branches?), regulation questions (what does glucagon do to glycogen synthase?), and clinical vignettes where you have to match a patient's phenotype — fasting hypoglycemia, exercise intolerance, cardiomegaly — to the correct enzyme deficiency. The glycogen storage diseases are a classic pattern-matching exercise, and the exam will give you partial information and expect you to distinguish GSD I from GSD III from GSD V based on subtle differences in clinical features.

What makes this topic tricky is the intersection of overlapping diseases and counterintuitive regulation. Students often reverse glucagon's effect on glycogen enzymes, thinking it promotes storage. They also lump Pompe disease in with the other cytoplasmic enzyme defects, missing that it's actually a lysosomal storage disease. And the McArdle vs. von Gierke confusion is extremely common — both involve glycogen accumulation, but the clinical pictures are essentially opposite. Nail the logic behind each disease (not just the enzyme name) and USMLE Step 1 becomes much more manageable here.

From real student decks
92%have cards covering this topic
89%have mature cards

Well-covered in most decks — the challenge is retention, not exposure.

Common misconceptions

Common mistake
Gap: Misses that muscle glycogen cannot contribute to blood glucose due to absent glucose-6-phosphatase
Muscle lacks glucose-6-phosphatase, so glycogen breakdown in muscle yields glucose-6-phosphate for local glycolysis only and cannot release free glucose into the bloodstream.
Muscle cells lack glucose-6-phosphatase, the enzyme that converts glucose-6-phosphate back to free glucose for export. This means when muscle breaks down glycogen via glycogen phosphorylase, the product (glucose-1-phosphate → glucose-6-phosphate) is trapped inside the cell and funneled directly into glycolysis. Muscle glycogen therefore serves only the muscle itself — it never contributes to blood glucose, which is why McArdle disease (muscle phosphorylase deficiency) does not cause fasting hypoglycemia.
Common mistake
Wrong: Glucagon activates glycogen synthase to promote glycogen storage.
Right: Glucagon activates glycogen phosphorylase (breakdown) and inactivates glycogen synthase (synthesis) via PKA-mediated phosphorylation.
Glucagon signals a low-glucose state and triggers breakdown, not storage. It activates adenylyl cyclase → cAMP → PKA, and PKA phosphorylates both glycogen synthase (inactivating it) and glycogen phosphorylase kinase (activating phosphorylase). So glucagon is pro-breakdown and anti-synthesis across the board. The mnemonic that helps: phosphorylation of glycogen enzymes always favors breakdown — phosphorylase gets activated, synthase gets inactivated.
Common mistake
Wrong: Pompe disease (GSD II) is caused by a cytoplasmic enzyme defect like other GSDs.
Right: Pompe disease is caused by deficiency of lysosomal acid alpha-1,4-glucosidase (acid maltase), making it unique among GSDs as a lysosomal storage disease.
Pompe disease stands apart from every other GSD because its deficient enzyme — acid alpha-1,4-glucosidase (acid maltase) — lives inside the lysosome, not the cytoplasm. Normally, lysosomes degrade glycogen that arrives via autophagy; in Pompe, that glycogen accumulates inside lysosomes and causes massive organomegaly, especially cardiomegaly. This lysosomal mechanism explains why Pompe presents so differently (infantile cardiomegaly, hypotonia) compared to the hepatic and metabolic phenotypes of GSD I and III.
Common mistake
Wrong: McArdle disease (GSD V) causes fasting hypoglycemia like von Gierke disease (GSD I).
Right: McArdle disease causes exercise-induced muscle cramps and myoglobinuria but no hypoglycemia, because the defect is in muscle phosphorylase only.
Von Gierke (GSD I) is a liver disease — glucose-6-phosphatase is absent in the liver, so the liver cannot release glucose during fasting, producing severe fasting hypoglycemia with hepatomegaly. McArdle (GSD V) is a pure muscle disease — muscle phosphorylase is absent, so exercising muscle cannot break down its glycogen for energy, causing cramps and myoglobinuria during exercise. Blood glucose is completely normal in McArdle because liver glycogen metabolism is intact. The key distinguishing feature is timing: von Gierke symptoms occur at rest/fasting, McArdle symptoms occur only with exercise.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know the enzymes responsible for glycogen synthesis (glycogen synthase makes alpha-1,4 bonds; branching enzyme creates alpha-1,6 branch points) and breakdown (glycogen phosphorylase cleaves alpha-1,4 bonds releasing glucose-1-phosphate; debranching enzyme handles alpha-1,6 branch points), and be able to identify which bond type each enzyme acts on.
  2. Understand how glucagon and insulin oppositely regulate glycogen synthase and glycogen phosphorylase through PKA-mediated phosphorylation — glucagon activates breakdown and inhibits synthesis, while insulin does the reverse — and be able to apply this logic to a clinical or biochemical scenario.
  3. Distinguish glycogen storage diseases I, II, III, and V by their deficient enzyme, the tissue affected, and the clinical phenotype — specifically who gets fasting hypoglycemia, who gets exercise intolerance without hypoglycemia, who has cardiomegaly, and which disease is lysosomal rather than cytoplasmic.

Can you avoid these mistakes?

A patient with McArdle disease (GSD V) is asked to fast overnight for a procedure. Would you expect his fasting blood glucose to be low, normal, or high? Explain why using the underlying enzyme defect.
Glucagon is released during a fast. Trace the signaling cascade from glucagon receptor to the final phosphorylation state of glycogen synthase and glycogen phosphorylase — and state whether each enzyme is more or less active as a result.
An infant presents with massive cardiomegaly, profound hypotonia, and dies of cardiorespiratory failure by age 2. Glycogen is found accumulated inside lysosomes on electron microscopy. What enzyme is deficient, what is the disease, and why does glycogen accumulate in this specific compartment rather than in the cytoplasm?
Debranching enzyme has two catalytic activities. Name them, specify which bond each one acts on, and explain what would happen to glycogen structure if only the transferase activity were lost but the glucosidase activity were preserved.

Related topics

Gluconeogenesis Nucleotide and Nucleic Acid Structure DNA Replication DNA Repair Pathways Mutations and Their Consequences

See how your Anki deck covers this topic.

Upload your deck for a free audit →